%. and change in product sales mix since we invested in the new Company, KURON Co., Ltd on 3 March 2020. And DDD capacity variance loss increased from unused capacity. Gross Profit Gross profit for the

was THB 10,579.69 million, slightly rose by THB 102.69 million or 0.98% up as compared to 9M2016 mainly from increasing in sales and production volume. Gross Profit The consolidated gross profit in

Microsoft Word - MDA Q219 EN August 14, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent

% Revenue from franchise - - 1,836 -100% Other income 3,503 4,326 -19% 13,328 -74% Total Revenues 473,402 507,792 -7% 853,833 -45% Profit / (Loss) before interest and taxation (4,437) (73,654) 94% 233,778

reviewed the 1 st quarter financial statements as of May 31, 2017 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The Company has net profit attributed to owners of the parent

June 2017, the net profit was Baht 46.72 million, increased by 9.62 million or increasing by 25.9 percents in which performance for the company and its subsidiaries in the current three-month period

YOY 9M/2020 9M/2019 YOY Service revenue 905.64 590.71 53.31% 2,588.84 1,609.44 60.85% Gross profit 164.54 98.70 66.71% 433.60 252.42 71.78% Other income 10.75 - 100.00% 17.57 9.84 78.56% Expenses of

statements for the year ended February 28, 2018 which were audited by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The Company has net profit attributed to owners of the parent of 2,966 million baht

-patients department inclined by 24.6% and 8.9% respectively. Causing the increasing in the total revenue from Gastrointestinal diseases and seasonal diceases such as Nasopharyngitis, Influenza, Dengue Fever

profits were in amounts of Baht 4.37 million and Baht 5.10 million, increasing by Baht 0.73 million or accounted for 16.80%. The proportion of net profit incurred compared to the total revenue for the 2nd